Entero Health Peer Comparison
NSE: ENTERO | BSE: 544122
₹1,966.00
As on 19-Nov-2026 09:34IST
Market cap
₹8,646 Cr
Revenue (TTM)
₹7,644 Cr
P/E Ratio
62
P/B Ratio
4.9
Div. Yield
0 %
| Entero Health | Medi-Caps | Rubra Medicaments | Pentokey Organy | Maitri Enterprises | |
|---|---|---|---|---|---|
Market cap (₹ Cr) |
8,646 | 28 | 18 | 18 | 14 |
Revenue (₹ Cr) |
7,644 | 16 | 454 | -4 | 33 |
Net Profit (₹ Cr) |
191.80 | -0.05 | -0.23 | -0.11 | 1.27 |
Net Margin (%) |
2.50 | -0.22 | -0.05 | 3.07 | 3.86 |
RoE (%) |
8.35 | -0.04 | -1.00 | -1.06 | 23.32 |
Price to Earnings |
62.04 | -- | -- | -- | 10.99 |
Price-To-Book |
4.87 | 0.25 | 9.48 | 1.74 | 2.48 |
Income Statement (₹ Cr)
| Entero Health | Medi-Caps | Rubra Medicaments | Pentokey Organy | Maitri Enterprises | |
|---|---|---|---|---|---|
|
Operating Revenue
|
6,591.21 | 12.45 | 0.50 | 2.09 | 28.66 |
|
Total Income
|
6,610.45 | 20.66 | 0.50 | 2.50 | 28.70 |
|
Total Expenditure
|
6,325.26 | 21.85 | 0.44 | 2.29 | 26.49 |
|
EBITDA
|
265.96 | -9.40 | 0.06 | -0.20 | 2.17 |
|
Depreciation
|
43.29 | 1.81 | 0.01 | 0.00 | 0.07 |
|
EBIT
|
222.66 | -11.21 | 0.05 | -0.20 | 2.10 |
|
Interest
|
54.39 | 0.02 | 0.01 | 0.00 | 0.77 |
|
Other Income
|
19.24 | 8.21 | 0.00 | 0.41 | 0.04 |
|
Exceptional Items
|
-8.18 | -- | -- | -- | -1.04 |
|
Profit before Tax
|
179.34 | -3.02 | 0.05 | 0.20 | 0.33 |
|
Provision for Tax
|
33.50 | 0.01 | 0.02 | -- | 0.16 |
|
Profit after Tax
|
145.84 | -3.04 | 0.03 | 0.20 | 0.17 |
Liabilities (₹ Cr)
| Entero Health | Medi-Caps | Rubra Medicaments | Pentokey Organy | Maitri Enterprises | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
1,688.61 | 111.61 | 0.56 | 9.70 | 4.70 |
|
Minority Interest
|
63.94 | -- | -- | -- | -- |
|
Non-Current Liabilities
|
206.12 | 1.14 | 0.00 | -- | 3.85 |
|
Current Liabilities
|
1,587.57 | 2.71 | 0.09 | -0.26 | 7.70 |
|
Total Liabilities
|
3,600.22 | 115.46 | 0.65 | 9.44 | 16.36 |
Assets (₹ Cr)
| Entero Health | Medi-Caps | Rubra Medicaments | Pentokey Organy | Maitri Enterprises | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
1,037.80 | 68.44 | 0.00 | 1.51 | 4.05 |
|
Current Assets
|
2,503.13 | 47.02 | 0.65 | 7.93 | 12.19 |
|
Total Assets
|
3,600.22 | 115.46 | 0.65 | 9.44 | 16.36 |
|
Total Debt*
|
566.68 | 0.00 | 0.00 | -0.01 | 6.89 |
|
Net Current Assets
|
915.56 | 44.31 | 0.56 | 8.18 | 4.49 |
|
Contingent Liabilities
|
5.51 | -- | -- | 1.72 | 1.79 |
Cashflow (₹ Cr)
| Entero Health | Medi-Caps | Rubra Medicaments | Pentokey Organy | Maitri Enterprises | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
96.20 | -7.02 | 0.19 | 0.76 | 3.04 |
|
Cash Flow from Investing Activities
|
-303.06 | 7.11 | -0.18 | 1.45 | 1.23 |
|
Cash from Financing Activities
|
123.66 | -- | -- | -2.17 | -4.40 |
|
Net Cash Inflow / Outflow
|
-83.20 | 0.09 | 0.01 | 0.04 | -0.12 |
Ratios
Profitability Ratios
| Entero Health | Medi-Caps | Rubra Medicaments | Pentokey Organy | Maitri Enterprises | |
|---|---|---|---|---|---|
|
ROCE (%)
|
10.93 | -2.58 | 9.64 | 2.13 | 8.25 |
|
ROE (%)
|
8.57 | -2.61 | 4.66 | 2.12 | 3.66 |
|
ROA (%)
|
4.68 | -2.52 | 3.22 | 2.11 | 0.89 |
|
EBIT Margin (%)
|
4.33 | -9.59 | 12.08 | 9.77 | 7.74 |
|
Net Margin (%)
|
2.21 | -14.70 | 5.07 | 8.13 | 0.59 |
|
Cash Profit Margin (%)
|
2.87 | -9.88 | 6.64 | 9.72 | 0.85 |
Growth Ratios
| Entero Health | Medi-Caps | Rubra Medicaments | Pentokey Organy | Maitri Enterprises | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
29.35 | -51.14 | -55.75 | 152.97 | 50.74 |
|
EBIT Growth (%)
|
35.13 | -229.03 | 78.70 | -18.22 | 487.36 |
|
Net Profit Growth (%)
|
35.75 | -431.96 | -15.89 | -17.23 | 137.55 |
|
EPS Growth (%)
|
21.32 | -431.95 | -15.94 | -17.25 | 139.47 |
|
Book Value Growth (%)
|
-2.19 | -7.97 | 4.77 | 2.52 | 3.93 |
Valuation Ratios
| Entero Health | Medi-Caps | Rubra Medicaments | Pentokey Organy | Maitri Enterprises | |
|---|---|---|---|---|---|
|
Price / Earnings
|
47.12 | 0.00 | 275.35 | 108.06 | 64.91 |
|
Price / Book Value
|
3.22 | 0.26 | 12.53 | 2.26 | 2.45 |
|
Dividend Yield (%)
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
|
EV/EBITDA
|
20.43 | -23.82 | 115.38 | 77.88 | 8.11 |
|
Market Cap (₹ Cr)
|
5,420.61 | 28.93 | 6.99 | 21.95 | 11.52 |
Solvency Ratios
| Entero Health | Medi-Caps | Rubra Medicaments | Pentokey Organy | Maitri Enterprises | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.34 | 0.00 | 0.00 | 0.00 | 1.47 |
|
Short term debt to equity ratio
|
0.26 | -- | -- | 0.00 | 0.62 |
|
Current Ratio
|
1.58 | 17.34 | 6.92 | -30.88 | 1.58 |
|
Quick Ratio
|
1.05 | 16.26 | 6.92 | -29.61 | 0.84 |
|
Interest Coverage
|
4.30 | -137.05 | 10.12 | 204.20 | 1.43 |
Operating Efficiency Ratios
| Entero Health | Medi-Caps | Rubra Medicaments | Pentokey Organy | Maitri Enterprises | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
18.39 | 55.60 | 57.00 | 55.66 | 18.89 |
|
Asset Turnover
|
2.11 | 0.10 | 0.63 | 0.22 | 1.52 |
|
Receivable days
|
56.56 | 230.34 | 362.19 | 127.21 | 90.06 |
|
Inventory Days
|
41.57 | 90.05 | 0.00 | 57.18 | 77.78 |
|
Payable days
|
34.66 | 71.74 | -- | -13.44 | 86.82 |
|
Cash Conversion Cycle
|
63.47 | 248.65 | -- | 197.83 | 81.03 |